Melalite Forte Cream contains Hydroquinone 4% w/w, a well-established depigmenting agent used in the treatment of hyperpigmentation disorders such as melasma, freckles, and post-inflammatory hyperpigmentation. Hydroquinone acts by inhibiting the enzyme tyrosinase, which is essential in the biosynthesis of melanin, thereby reducing melanin production and leading to gradual lightening of hyperpigmented areas. This topical formulation is intended for external use and should be applied sparingly to affected areas once or twice daily, as directed by a healthcare professional. Patients are advised to avoid excessive sun exposure and use broad-spectrum sunscreen during treatment to prevent further pigmentation and protect sensitive skin. Melalite Forte Cream is contraindicated in individuals with hypersensitivity to hydroquinone or any component of the formulation, and caution is advised in patients with eczema or dermatitis. Prolonged use beyond the recommended duration should be avoided to minimize the risk of ochronosis, a rare but serious adverse effect characterized by paradoxical skin darkening. Pregnant or lactating women should consult their physician prior to use. As with all topical agents, discontinuation is recommended if irritation or allergic reaction occurs. Regular follow-up with a dermatologist is advised to monitor treatment efficacy and safety.